Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Di Fede

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
The Lancet. Neurology|January 14, 2014
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trialStéphane Haïk, Gabriella Marcon, Alain Mallet, et al.
Frontiers in Neurology|February 15, 2024
Distribution of the <i>C9orf72</i> hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitationEmiliano Giardina, Paola Mandich, Roberta Ghidoni, et al.
The Lancet. Neurology|July 15, 2026
Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort studyArabella Bouzigues, Mario Grassi, Valentina Cantoni, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variantsIsis So, Jolina Lombardi, Adam M Staffaroni, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
The Lancet. Neurology|January 14, 2014
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trialStéphane Haïk, Gabriella Marcon, Alain Mallet, et al.
Frontiers in Neurology|February 15, 2024
Distribution of the <i>C9orf72</i> hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitationEmiliano Giardina, Paola Mandich, Roberta Ghidoni, et al.
The Lancet. Neurology|July 15, 2026
Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort studyArabella Bouzigues, Mario Grassi, Valentina Cantoni, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variantsIsis So, Jolina Lombardi, Adam M Staffaroni, et al.
Pageof 9